High-dose procainamide in chronic renal failure

M. B. Bottorff, C. S. Kuo, R. L. Batenhorst

Research output: Contribution to journalArticlepeer-review


A patient with chronic renal failure who experienced symptomatic ventricular tachycardia was treated successfully with procainamide (PA) after numerous dosage adjustments to optimize his clinical response and serum PA and NAPA concentrations. Efforts to maintain total combined serum levels at 20-30 μg/ml led to sustained ventricular ectopy whenever the serum PA levels decreased to < 8 μg/ml.

Original languageEnglish
Pages (from-to)279-281
Number of pages3
JournalDrug Intelligence and Clinical Pharmacy
Issue number4
StatePublished - 1983

ASJC Scopus subject areas

  • General Pharmacology, Toxicology and Pharmaceutics
  • Pharmacology (medical)


Dive into the research topics of 'High-dose procainamide in chronic renal failure'. Together they form a unique fingerprint.

Cite this